Cargando…
Reactivation of minimal change disease and IgA nephropathy after COVID-19 vaccination
Autores principales: | Leong, Leanne Ca-Yin, Hong, Wei-Zhen, Khatri, Priyanka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690238/ https://www.ncbi.nlm.nih.gov/pubmed/35198161 http://dx.doi.org/10.1093/ckj/sfab241 |
Ejemplares similares
-
Safety Evaluation of COVID-19 Vaccine in Patients With IgA Nephropathy or IgA Vasculitis Nephritis
por: Zan, Jincan, et al.
Publicado: (2022) -
IgA nephropathy following COVID-19 vaccination: challenges and perspectives
por: Niel, Olivier, et al.
Publicado: (2022) -
R: IgG deposition in IgA nephropathy patients
por: Baradaran, Azar
Publicado: (2013) -
IgA Nephropathy in a Patient with IgG Myeloma
por: Lakshmi, B. Sangeeta, et al.
Publicado: (2018) -
IgA nephropathy in IgG kappa multiple myeloma
por: Couto, Maria Eduarda, et al.
Publicado: (2021)